Drug Profile
ARA 1
Alternative Names: ARA-1Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator ARA Healthcare
- Class Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Cancer in India (unspecified route)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Cancer in India
- 30 Jun 2016 Preclinical trials in Cancer in India (unspecified route)